HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

Stada Partners With NTC For Ophthalmic Brands In MENA

Stada has struck a deal to partner with Italy’s NTC to market a portfolio of ophthalmic brands in the MENA region.

Middle East and Africa Deals

EU Business Round-Up: BioGaia Seeks Bigger Slice Of UK, Acino Gets Middle East Backers, Boots Moves Into Advertising

The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.

Europe Business Strategies

Royal DSM Fills Plate With Nutrition, Health And Bioscience, Plans To Slice Off Chemical Business

Sale is among options it’s considering for materials business, which is currently “managed largely on a standalone basis.” Its health, nutrition and bioscience segments account for 80% to 85% of total sales and will operate as individual business groups.

M & A Dietary Supplements
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

People On The Move: Appointments At GSK, Stada And Sanofi

The latest appointments in Europe's consumer health industry: GSK promotes Davide Fanelli to lead its business in Spain; Stada appoints Marc van Boven to a newly-created role; and Sanofi hires Theresa von Fugle to manage its OTC operation in Germany.

Executive Changes Leadership

Stada Partners With NTC For Ophthalmic Brands In MENA

Stada has struck a deal to partner with Italy’s NTC to market a portfolio of ophthalmic brands in the MENA region.

Middle East and Africa Deals

EU Business Round-Up: BioGaia Seeks Bigger Slice Of UK, Acino Gets Middle East Backers, Boots Moves Into Advertising

The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.

Europe Business Strategies
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Germany’s PharmaSGP Predicts Market Turnaround Despite Difficult First Half

Germany's PharmaSGP blamed ongoing lockdowns for falling first-half sales, but said it could see light at the end of the tunnel, with the OTC market expected to recover in the second half of the year.

Sales & Earnings Germany

Stada Expands Portfolio In US And Nordics As First-Half Sales Rise

Stada reported Branded Products sales up 9% in the first half as it secured two additions to its portfolio, with a US dietary supplement brand and Nordic herbal analgesic.

Deals Sales & Earnings

EU Business Round-Up: Midsona Acquires Finland's Vitality, Karo Hires CCO From J&J, Navamedic Sees OTC Sales Rise

The latest European business news: Sweden's Midsona expands its consumer health offering by acquiring Finland's Vitality; Karo Pharma hires J&J exec as CCO; and Navamedic sees sales rise driven by OTC growth. 

Europe Deals
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

Perrigo Continues Overhaul Adding HRA Pharma, Boosts Chances For OTC Oral Contraceptive In US

HRA’s approval for pharmacy sales of a daily oral contraceptive the UK and its ongoing work on an NDA to propose making another progestin-only contraceptive ingredient available OTC in the US stand out as additions to Perrigo’s business with the most substantial revenue impacts.

M & A OTC Drugs

Perrigo Expects Settlement To Lower Irish Tax Debt

Ireland’s Office of Revenue concluded it “would not object if the Tax Appeals Commission adjusted the amount of the assessment to less than 1 billion,” says Perrigo CEO Murray Kessler.

OTC Drugs Legal Issues

Plaintiffs Say Benzene-Tainted Banana Boat Sunscreens Are Deceptive, Adulterated And Thus ‘Worthless’

Putative class actions against sunscreen product manufacturers for alleged violations of federal and state laws due to benzene contamination can be traced to testing reported in May by independent quality assurance firm Valisure, which bills itself as “the pharmacy that checks.”

United States Legal Issues
See All
UsernamePublicRestriction

Register